Gentler radiation zaps eye lymphoma with fewer side effects

NCT ID NCT02494700

Summary

This study is testing whether a very low dose of radiation aimed at the eye socket can effectively control slow-growing B-cell lymphomas that involve the eye area. It aims to see if this lower dose can work as well as standard treatments while causing fewer side effects. The trial is for adults with specific types of slow-growing lymphoma and is currently not enrolling new participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.